Ultragenyx Pharmaceutical(RARE) - 2025 Q4 - Earnings Call Transcript
Ultragenyx Pharmaceutical(US:RARE)2026-02-12 23:02Ultragenyx Pharmaceutical (NasdaqGS:RARE) Q4 2025 Earnings call February 12, 2026 05:00 PM ET Company ParticipantsEmil Kakkis - CEOEric Crombez - CMOErik Harris - CCOHoward Horn - CFOJoshua Higa - VP of Investor RelationsLydia Edelman - Biotech Equity Research AssociateMaxwell Skor - Vice President, Biotech Equity ResearchPriyanka Nagpal - Vice President - Change ManagementRick Miller - Vice President, Biotech Equity ResearchTara Ahmad - AVP, Testing Specialist IWill Soghikian - Research AssociateYigal Dov ...